11 Mar 2014
Glycotope secures one of the largest financing rounds in the European biotech sector
Read press release
25 Nov 2013
Glycotope Doses First Patients in Phase IIb Study with PankoMab-GEX™ for the Maintenance Therapy of Ovarian Carcinoma
Read press release
18 Nov 2013
Glycotope’s Fully Human and Glycooptimized Recombinant FSH-GEX™ Showed Superior Activity and Excellent Tolerability in a Phase II Clinical Trial for In Vitro Fertilisation
Read press release
16 Oct 2013
Glycotope Reported Promising First-in-Man Data of Novel Glycooptimized Monoclonal Anti-TA-MUC1 Antibody PankoMab-GEX™
Read press release